RxDoctor Payments Data

Amy Kilen

Gerontology · Baltimore, MDNPI 1588155428

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,044 and has fallen 88.8% since, to $117 in 2024.

$2,150in general payments, 2019–2025

Across 19 payments — averaging $113.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$449
  • Novo Nordisk$237
  • AbbVie$215
  • Idorsia Pharmaceuticals US Inc$211
  • Boston Scientific$138
  • Janssen Scientific Affairs, LLC$125
  • plus $774 from 7 others

What the payments were for

  • Food & beverage$2,150100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,150 in reported general payments places this provider in the 85th percentile of 108 gerontology providers in Maryland.

See all gerontology providers in Maryland

Medicare billing

Part B allowed, 2024
$33,720
Medicare patients
92
Services billed
272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$52,193
JardianceEmpagliflozin29$26,068
EntrestoSacubitril/Valsartan12$10,296
Atorvastatin Calcium88$1,181
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic12$1,058
Pantoprazole Sodium36$870
Mirtazapine18$869
Levothyroxine Sodium50$569
Gabapentin37$564
Metoprolol Succinate42$374
Oxycodone Hcl23$340
Losartan Potassium22$327
Amlodipine Besylate37$299
Latanoprost35$239
Duloxetine Hcl12$239

Paid to pharmacies, not to this prescriber.

Other gerontology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →